Combinational Treatment of Doxorubicin With Neoadjuvant Docetaxel for Different Subtypes of Patients With Breast Cancer
Aim: The aim of this study is to characterize the effect of chemotherapy drug doxorubicin with neoadjuvant drug docetaxel for different molecular subtypes. Methods: A total of 83 patients with late-stage breast cancer were chosen to undergo treatment and compared to these patients to the combination...
Main Authors: | Ling-Cheng Wang MD, Ling-Sheng Wang BM, Ai-Xia Li BM, Zhen-Zong Shi MM, Ya-Qiong Li MM, Wei Huang MM, Shi-Man Chen MM, Fei Han BM, De-Qiang Zhu BM |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-06-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/1533033820928435 |
Similar Items
-
Intra- and Peritumoral-Based Radiomics for Preoperatively Assessing the Pathological Subtype of T1-Stage Lung Adenocarcinoma Presenting as Pure Ground-Glass Nodules
by: Wenting Jiang BM, et al.
Published: (2024-12-01) -
RETRACTED: Long Noncoding RNA FGD5-AS1 Knockdown Decrease Viability, Migration, and Invasion of Non-Small Cell Lung Cancer (NSCLC) Cells by Regulating the MicroRNA-944/MACC1 Axis
by: Jian Lv MM, et al.
Published: (2021-02-01) -
LncRNA NEAT1 Promotes Vascular Endothelial Cell Dysfunction via miR-218-5p/GAB2 and Serves as a Diagnostic Biomarker for Deep Vein Thrombosis
by: Shuping Wang BM, et al.
Published: (2023-06-01) -
Inhibition of Microrna-766-5p Attenuates the Development of Cervical Cancer Through Regulating SCAI
by: Yongqin Cai BM, et al.
Published: (2020-12-01) -
Expression and Regulatory Network Analysis of MiR-139-3p, a New Potential Serum Biomarker for Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis
by: Yonghong Wang MM, et al.
Published: (2020-04-01)